Resilience Capacity Update April 2025: Fill/Finish

Resilience is an end-to-end CDMO with 7 North American sites serving small, mid-size, and large pharmaceutical and biotechnology companies, including 3 FDA-approved commercial Drug Product manufacturing sites. Here, we share our existing capacity and expansion plans to meet market demands for vials, pre-filled syringes, cartridges, device assembly & packaging. In this update, you will hear from Evan Pasenello, Head of Commercial Services, about how Resilience can support manufacturing programs from clinical through commercial.